PAM
ALDX icon

Premier Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History

Premier Asset Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-128,579
Closed -$1.46M – 163
2021
Q2 		$1.46M Buy
128,579
+72,074
+128% +$867K 0.22% 74
2021
Q1 		$671K Buy
+56,505
New +$651K 0.12% 104

Other funds holding ALDX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Premier Asset Management's ALDX Position: Q3 2021 in Review

Premier Asset Management sold out of Aldeyra Therapeutics (ALDX) in Q3 2021, closing a stake of 128,579 shares — an estimated $1.46M sold.

Premier Asset Management first reported a position in ALDX in Q1 2021 and held it in 2 quarters. The position peaked at $1.46M in Q2 2021. 117 funds tracked by Wall St. Rank hold ALDX as of Q3 2021.

  • Premier Asset Management reported no remaining Aldeyra Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Premier Asset Management sold 128,579 Aldeyra Therapeutics shares in Q3 2021, an estimated $1.46M.
  • Premier Asset Management first reported a position in Aldeyra Therapeutics in Q1 2021 and held it in 2 quarters.
  • Premier Asset Management's Aldeyra Therapeutics position peaked at $1.46M in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2021.

Based on Premier Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.